CHEK Check Cap Ltd

USD 2.26 0.08 3.669725
Icon

Check Cap Ltd (CHEK) Stock Analysis and Price Targets

COMMON STOCK | Diagnostics & Research | NSD
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 2.26

+0.08 (+3.67)%

USD 0.01B

0.04M

N/A

N/A

Icon

CHEK

Check Cap Ltd (USD)
COMMON STOCK | NSD
USD 2.26
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.01B

N/A

USD 2.26

Check Cap Ltd (CHEK) Stock Forecast

N/A

Based on the Check Cap Ltd stock forecast from 0 analysts, the average analyst target price for Check Cap Ltd is not available over the next 12 months. Check Cap Ltd’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Check Cap Ltd is Slightly Bearish, which is based on 3 positive signals and 4 negative signals. At the last closing, Check Cap Ltd’s stock price was USD 2.26. Check Cap Ltd’s stock price has changed by -5.83% over the past week, +19.20% over the past month and +67.41% over the last year.

No recent analyst target price found for Check Cap Ltd
No recent average analyst rating found for Check Cap Ltd

Company Overview Check Cap Ltd

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-...Read More

https://www.check-cap.com

Check-Cap Building, Isfiya, Israel, 3009000

85

December

USD

USA

Adjusted Closing Price for Check Cap Ltd (CHEK)

Loading...

Unadjusted Closing Price for Check Cap Ltd (CHEK)

Loading...

Share Trading Volume for Check Cap Ltd Shares

Loading...

Compare Performance of Check Cap Ltd Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for CHEK

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Check Cap Ltd (Sector: Diagnostics & Research )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
IDXX
IDEXX Laboratories Inc -0.45 (-0.09%) USD44.10B 52.65 36.72

ETFs Containing CHEK

Symbol Name CHEK's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Check Cap Ltd (CHEK) Stock

Stock Target Advisor's fundamental analysis for Check Cap Ltd's stock is Slightly Bearish.

Unfortunately we do not have enough data on CHEK's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on CHEK's stock to indicate what its average analyst target is.

CHEK stock's Price/Earning ratio is 0.20. Our analysis grades CHEK stock's Price / Earning ratio at A-. This means that CHEK stock's Price/Earning ratio is above 9.999999999999998% of the stocks in the Diagnostics & Research sector in the NSD exchange. Based on this CHEK may be undervalued for its sector.

The last closing price of CHEK's stock was USD 2.26.

The most recent market capitalization for CHEK is USD 0.01B.

Unfortunately we do not have enough analyst data on CHEK's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Check Cap Ltd's stock.

As per our most recent records Check Cap Ltd has 85 Employees.

Check Cap Ltd's registered address is Check-Cap Building, Isfiya, Israel, 3009000. You can get more information about it from Check Cap Ltd's website at https://www.check-cap.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...